TMLI/Fludarabine/Melphalan Conditioning for Allogeneic Transplantation in High-risk Myelodysplastic Syndrome or Acute Myeloid Leukemia.

NCT06602323 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Myelodysplastic Syndromes
Acute Myeloid Leukemia

Interventions

COMBINATION_PRODUCT: TMLI/Flu/Mel

Sponsor

Fundación Pública Andaluza para la gestión de la Investigación en Sevilla